Risk Assessment in Patients With Tricuspid Valve Regurgitation: MELD and Beyond

J Am Coll Cardiol. 2020 Dec 22;76(25):2977-2979. doi: 10.1016/j.jacc.2020.11.009. Epub 2020 Nov 9.

Authors

Ali N Zaidi¹, David H Adams²

Affiliations

¹ Mount Sinai Adult Congenital Heart Disease Center, Mount Sinai Cardiovascular Institute & The Children's Heart Center, Mount Sinai Kravis Children's Hospital, New York, New York, USA. Electronic address: ali.zaidi@mountsinai.org.
² Department of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

PMID: 33181244
DOI: 10.1016/j.jacc.2020.11.009

No abstract available

Keywords: MELD; risk assessment; tricuspid regurgitation.

Publication types

Editorial
Comment

MeSH terms

Ebstein Anomaly*
Humans
Prognosis
Risk Assessment
Tricuspid Valve / diagnostic imaging
Tricuspid Valve / surgery
Tricuspid Valve Insufficiency* / diagnostic imaging